Mounjaro vs Compounded Tirzepatide: $499 or $69 a Month
Mounjaro costs $499 a month from the manufacturer, while compounded tirzepatide starts at $69 a month (Collective), a gap of $430 a month or $5,160 over 12 months.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
12 months of Mounjaro or compounded tirzepatide
| Option | Monthly | 12 months |
|---|---|---|
| Mounjaro at list price | $1,112/mo | $13,344 |
| Compounded tirzepatide, middle price of 394 sellers | $249/mo | $2,988 |
| Compounded tirzepatide, cheapest seller (Collective) | $69/mo | $828 |
What Mounjaro costs without insurance
Mounjaro is approved for type 2 diabetes. Lilly sells it to cash buyers through LillyDirect starting at $499 a month at every strength, against a list price of about $1,112. Zepbound, the same tirzepatide, costs $299 to $449 a month through LillyDirect on the discounted schedule.
There are two Mounjaro savings cards, both for people with commercial insurance. If the plan covers Mounjaro, a fill of up to three months can come down to $25. If the plan refuses it, a separate card puts a month at $499. Both require an approved use, which means type 2 diabetes, and both end December 31, 2026. Lilly Cares does not include Mounjaro.
Our picks for compounded tirzepatide
The 12 cheapest compounded tirzepatide sellers
Standing monthly price for the injection, lowest first. First-month offers, microdose and oral tiers, and fee-only plans are left out.
| # | Seller | Monthly price | Score | Visit |
|---|---|---|---|---|
| 1 | Collective | $69/mo | 9.1 | Visit |
| 2 | WeightRx | $83/mo | 6.6 | Review |
| 3 | Nu Image Medical | $89/mo | 7.1 | Review |
| 4 | WellMedRx | $89/mo | 6.3 | Visit |
| 5 | YourEra | $99/mo | 9.0 | Visit |
| 6 | Optimize HP | $99/mo | 8.8 | Review |
| 7 | Vivanta Care | $99/mo | 8.3 | Review |
| 8 | Teleios Health | $99/mo | 7.3 | Review |
| 9 | Framework | $100/mo | 8.8 | Review |
| 10 | NextMeds | $109/mo | 9.3 | Review |
| 11 | Mint Med FDA warning letter, see review | $119/mo | 8.3 | Review |
| 12 | LumiMeds FDA warning letter, see review | $125/mo | 6.2 | Review |
All 394 sellers, side by side: the full price table or compare sellers.
What compounded tirzepatide costs instead
389 of the 394 sellers who post a standing monthly price for compounded tirzepatide injections charge less than Mounjaro's $499 LillyDirect price, and 206 charge less than half of it. The cheapest is Collective at $69; the middle price is $249.
Mounjaro's LillyDirect price is the same at 2.5 mg and 15 mg, and compounded pricing is not always as steady: 37 tirzepatide sellers say their price goes up with the dose, against 136 that keep one flat price. Ask for the price at the dose you expect to reach before you sign up.
Mounjaro or compounded tirzepatide over 12 months
12 months at the $499 LillyDirect self-pay price, which does not change with the dose. Zepbound on LillyDirect is the same molecule for less at every Journey Program step. That comes to $5,988 for a year of Mounjaro. The same 12 months of compounded tirzepatide costs $828 at the cheapest seller and $2,988 at the middle price, which keeps $5,160 or $3,000 in your pocket.
Mounjaro is Lilly's approved tirzepatide pen for type 2 diabetes, in six strengths from 2.5 to 15 mg. Compounded tirzepatide contains the same active ingredient but is prepared by a pharmacy for one patient, and the FDA does not review the finished product. A Mounjaro prescription can also use Lilly's diabetes savings cards; a compounded vial cannot.
Where to buy Mounjaro itself online
17 sellers post a standing monthly price for Mounjaro. The lowest are Noom ($349/mo), Mochi Health ($499/mo) and Vital Edge ($835/mo). A seller's price can sit above the manufacturer's own because it adds a clinician visit or a membership to the medication.
FDA warning letters on compounded tirzepatide
The FDA has sent 114 warning letters that name tirzepatide to sellers and compounders, 65 of them dated 2026. The subject lines FDA used most often are "False & Misleading Claims/Misbranded" (55) and "Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet" (35).
11 letters name Mounjaro itself in the summary or the passages quoted on our letter pages; the most recent went to Eli Lilly and Company in September 2025.
Among the 12 cheapest sellers listed on this page, we found an FDA warning letter issued to Mint Med and LumiMeds. Each review says what the letter cited.
Frequently Asked Questions
Coupons and savings cards for Mounjaro: Mounjaro savings options | Other comparisons: all brand vs compounded pages